Global Anticoagulants Market Size & Outlook, 2024-2030
Global anticoagulants market, 2018-2030 (US$M)
Related Markets
Global anticoagulants market highlights
- The global anticoagulants market generated a revenue of USD 35,957.0 million in 2024 and is expected to reach USD 47,101.0 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 4.6% by 2030.
- In terms of segment, novel oral anticoagulants (noacs) accounted for a revenue of USD 20,560.9 million in 2024.
- Heparin is the most lucrative drug category segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 35,957.0 million |
| Market revenue in 2030 | USD 47,101.0 million |
| Growth rate | 4.6% (CAGR from 2025 to 2030) |
| Largest segment | Novel oral anticoagulants (noacs) |
| Fastest growing segment | Heparin |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Vitamin K Antagonist, Direct Thrombin Inhibitors, Novel Oral Anticoagulants (NOACs), Heparin |
Other key industry trends
- In terms of revenue, the North America accounted for 51.1% of the global anticoagulants market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, China is the fastest growing regional market and is projected to reach USD 1,946.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anticoagulants Market Scope
Anticoagulants Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global anticoagulants market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anticoagulants market will help companies and investors design strategic landscapes.
Novel oral anticoagulants (noacs) was the largest segment with a revenue share of 57.18% in 2024. Horizon Databook has segmented the Global anticoagulants market based on vitamin k antagonist, direct thrombin inhibitors, novel oral anticoagulants (noacs), heparin covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Anticoagulants Drug Category Outlook (Revenue, USD Million, 2018-2030)
- Vitamin K Antagonist
- Direct Thrombin Inhibitors
- Others
- Novel Oral Anticoagulants (NOACs)
- Eliquis
- Xarelto
- Savaysa & lixiana
- Pradaxa
- Heparin
- Low Molecular Weight Heparin
- Ultra-low Molecular Weight Heparin
- Unfractionated Heparin
- Global Anticoagulants Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral Anticogulants
- Injectable Anticogulants
- Global Anticoagulants Application Outlook (Revenue, USD Million, 2018-2030)
- Atrial Fibrillation/Myocardial Infarction (Heart Attack)
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism
- Other Applications
Reasons to subscribe to Global anticoagulants market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global anticoagulants market databook
-
Our clientele includes a mix of anticoagulants market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global anticoagulants market , including forecasts for subscribers. This global databook contains high-level insights into Global anticoagulants market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global anticoagulants market size, by regions, 2018-2030 (US$M)
Top 10 countries: Anticoagulants market size, 2023 (US$M)
Global anticoagulants market share, by drug category, 2023 & 2030 (%, US$M)
Anticoagulants market: Opportunity assessment by country
Global anticoagulants market, by region, 2024 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
